Dr. Jose Daniel Diaz , MD
Ophthalmology โข Miami, FL
2601 Sw 37th Ave Ste 501
Miami, FL 331332750
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 9, 2015; this date does not establish years in practice.
-
Published CMS data list 5,705 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 โ Injection, faricimab-svoa, 0.1 mg: 4,081 service units.
- 92134 โ Imaging of retina: 517 service units.
- 92014 โ Established patient complete exam of visual system: 295 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 10 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 450 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Eylea (Aflibercept) โ 73 prescription fills, including refills.
- Prednisolone Acetate โ 61 prescription fills, including refills.
- Latanoprost โ 58 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 13 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Miami, FL (2024, 114 clinicians with data). Median for this group: 849. Middle half: 287 to 1,931.
More Medicare Part B services than 80% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: 2,189. Middle half: 818 to 4,724.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 28 in 2020 to 5,705 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
2601 Sw 37th Ave Ste 501
Miami, FL 331332750
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Coral Gables, FL. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 3 distinct group names: Dan Hoffman Md Pa; Isidoro Zarco Md Pa; Retina Consultants Of Miami. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Albert Einstein College Of Medicine Of Yeshiva University
2015
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
284 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $415,624 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $322,276 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
593 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$230,496 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,217.54 across 22 records.
By nature of payment
- Food and Beverage: $1,217.54 across 22 records.
Reporting-company totals (3 largest of 11)
- Astellas Pharma US Inc: $232.06 across 6 records.
- Mallinckrodt Hospital Products Inc.: $184.22 across 4 records.
- Regeneron Pharmaceuticals, Inc.: $183.75 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
11 years (graduated 2015)
CMS Doctors and Clinicians data list 2015 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2015
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Diaz has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Diaz as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Miami, FL (2024, 114 clinicians with data). Median for this group: 849. Middle half: 287 to 1,931.
More Medicare Part B services than 80% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: 2,189. Middle half: 818 to 4,724.
Medicare-allowed amount
A higher Medicare-allowed amount than 85% of clinicians listed under Ophthalmology in Miami, FL (2024, 114 clinicians with data). Median for this group: $89,293. Middle half: $27,087 to $217,961.
A higher Medicare-allowed amount than 65% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: $242,390. Middle half: $87,419 to $538,035.
Paid by Medicare
A higher Medicare payment amount than 85% of clinicians listed under Ophthalmology in Miami, FL (2024, 114 clinicians with data). Median for this group: $64,425. Middle half: $19,303 to $163,999.
A higher Medicare payment amount than 65% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: $175,695. Middle half: $62,701 to $392,398.
Medicare Part D prescriptions
Fewer Part D prescriptions than 65% of clinicians listed under Ophthalmology in Miami, FL (2024, 145 clinicians with data). Median for this group: 1,158. Middle half: 229 to 3,187.
Fewer Part D prescriptions than 70% of clinicians listed under Ophthalmology in Florida (2024, 1,099 clinicians with data). Median for this group: 1,203. Middle half: 441 to 2,500.
Part D drug cost
A higher Part D drug cost than 65% of clinicians listed under Ophthalmology in Miami, FL (2024, 145 clinicians with data). Median for this group: $92,831. Middle half: $8,977 to $318,793.
A higher Part D drug cost than 65% of clinicians listed under Ophthalmology in Florida (2024, 1,099 clinicians with data). Median for this group: $115,029. Middle half: $23,964 to $310,282.
218 active clinicians are listed under Ophthalmology with a practice address in Miami, FL (1,584 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
10.6% of these 218 clinicians have the CMS telehealth indicator.
64.2% of these 218 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 20275% from 28 in 2020 to 5,705 in 2024.
- 2020: 28
- 2021: 332
- 2022: 1,506
- 2023: 1,642
- 2024: 5,705
-
Medicare-allowed amount
Medicare-allowed amount increased 19970% from $2,071 in 2020 to $415,624 in 2024.
- 2020: $2,071
- 2021: $27,342
- 2022: $129,130
- 2023: $319,955
- 2024: $415,624
-
Paid by Medicare
Paid by Medicare increased 20869% from $1,537 in 2020 to $322,276 in 2024.
- 2020: $1,537
- 2021: $21,408
- 2022: $98,253
- 2023: $249,768
- 2024: $322,276
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 379% from 94 in 2019 to 450 in 2024.
- 2019: 94
- 2021: 49
- 2022: 440
- 2023: 459
- 2024: 450
-
30-day fills
30-day fills increased 332% from 137 in 2019 to 593 in 2024.
- 2019: 137
- 2021: 54
- 2022: 548
- 2023: 592
- 2024: 593
-
Part D drug cost
Part D drug cost increased 5675% from $3,991 in 2019 to $230,496 in 2024.
- 2019: $3,991
- 2021: $662
- 2022: $284,478
- 2023: $238,533
- 2024: $230,496
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $814.42 in 2021 to $1,217.54 in 2025.
- 2021: $814.42
- 2022: $1,747.36
- 2023: $1,272.04
- 2024: $994.50
- 2025: $1,217.54
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 22 records totaling $1,217.54.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Clareon PanOptix Pro | General | $146.19 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $121.87 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $121.83 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $121.60 |
| CooperVision Inc. |
Food and Beverage
In-kind items and services
|
MyDay Contact Lens | General | $107.38 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $99.10 |
| LKC Technologies, Inc. |
Food and Beverage
In-kind items and services
|
โ | General | $90.09 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $35.04 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Syfovre | General | $34.10 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $33.02 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $32.96 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $31.50 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $30.83 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $30.24 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Susvimo | General | $28.95 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $27.28 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $27.11 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ILUVIEN | General | $25.08 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $24.87 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $21.92 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $17.60 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $8.98 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2019โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
4,081 | 12 | $38.00 | $34.79 |
|
92134
Imaging of retina
|
517 | 241 | $85.71 | $41.18 |
|
92014
Established patient complete exam of visual system
|
295 | 210 | $212.07 | $127.27 |
|
67028
Injection of drug into eye
|
274 | 76 | $280.22 | $127.58 |
|
J0178
Injection, aflibercept, 1 mg
|
176 | 28 | $1031.25 | $823.64 |
|
J7999
Compounded drug, not otherwise classified
|
121 | 42 | $89.59 | $80.20 |
|
92004
New patient complete exam of visual system
|
87 | 87 | $305.02 | $150.52 |
|
92012
Established patient problem focused exam of visual system
|
79 | 52 | $158.94 | $90.29 |
|
92250
Photography of the retina
|
57 | 54 | $80.26 | $36.56 |
|
92235
Exam of retinal blood vessels using a special camera after injection of a dye
|
18 | 18 | $309.50 | $159.87 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Eylea | Aflibercept | 73 | 2,052 | $202,435.45 | 24 |
| Prednisolone Acetate | Prednisolone Acetate | 61 | 1,854 | $1,890.78 | 38 |
| Latanoprost | Latanoprost | 58 | 2,490 | $478.64 | 24 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 52 | 1,379 | $676.45 | 32 |
| Timolol Maleate | Timolol Maleate | 41 | 1,905 | $417.04 | 15 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 38 | 1,036 | $1,539.28 | 21 |
| Difluprednate | Difluprednate | 25 | 654 | $2,577.85 | โ |
| Restasis | Cyclosporine | 24 | 1,260 | $14,602.08 | โ |
| Brimonidine Tartrate | Brimonidine Tartrate | 24 | 785 | $965.64 | โ |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | 1,281 | $295.43 | โ |
| Lumigan | Bimatoprost | 13 | 320 | $3,256.22 | โ |
| Dorzolamide Hcl | Dorzolamide Hcl | 13 | 755 | $132.18 | โ |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 11 | 330 | $1,228.99 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-03-31NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0107X
An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20190815000567
FL
9032427232
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Retina Consultants Of Miami
2601 Sw 37th Ave, Miami, FL 331332750
Phone: 3057126711
Dan Hoffman Md Pa
1701 Ne 164th St, North Miami Beach, FL 331624018
Phone: 3059470027
Dan Hoffman Md Pa
5333 N Dixie Hwy, Oakland Park, FL 333343414
Phone: 9544935033
Isidoro Zarco Md Pa
3230 W Flagler St, Miami, FL 331351153
Isidoro Zarco Md Pa
3230 W Flagler St, Miami, FL 331351153
Phone: 3054433330
Secondary Practice Locations
1097 S Lejeune Rd
Coral Gables, FL 33134
Phone: 3054422020
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 2601 SW 37TH AVE STE 501, MIAMI, FL 331332750 (Tel: 3057126711)
Registered at 2601 SW 37TH AVE STE 501, MIAMI, FL 331332750 (Tel: 3057126711)
Additional practice office at 1097 S LEJEUNE RD, CORAL GABLES, FL 33134
Ophthalmology (license number reported to NPPES: FL ME140307)
Ophthalmology (license number reported to NPPES: FL ME140307)
Registered at 2601 SW 37TH AVE STE 907, MIAMI, FL 331332751 (Tel: 3057126711)
Registered at 2601 SW 37TH AVE STE 907, MIAMI, FL 331332751 (Tel: 3057126711)
Registered at 950 BRICKELL BAY DR APT 5007, MIAMI, FL 331313963 (Tel: 3057946117)
Ophthalmology (license number reported to NPPES: FL ME140307)
Registered at 900 NW 17TH ST, MIAMI, FL 331361119 (Tel: 3052432020)
Registered at 900 NW 17TH ST, MIAMI, FL 331361119 (Tel: 3052432020)
NPI status registered as active in NPPES database
Registered at MASSACHUSETTS GENERAL HOSPITAL, 55 FRUIT ST., BOSTON, MA 02114 (Tel: 6177265820)
Registered at MASSACHUSETTS GENERAL HOSPITAL, 55 FRUIT ST., BOSTON, MA 02114 (Tel: 6177265820)
Recorded as JOSE DIAZ, MD
Internal Medicine (license number reported to NPPES: MA L-263023)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Miami
- Dr. Craig Mckeown, MD
- Dr. Dominick Canady, MD
- Dr. Kara Cavuoto, MD
- Dr. Alcina Lidder, MD
- Dr. Rafael Ortiz, MD
- Dr. Donald Budenz, MD
Mailing Address
2601 Sw 37th Ave Ste 501
Miami, FL 331332750
Phone: 3057126711